Intracoronary Imaging, Cholesterol Efflux, and Transcriptomics after Intensive Statin Treatment in Diabetes

Abstract Residual atherothrombotic risk remains higher in patients with versus without diabetes mellitus (DM) despite statin therapy. The underlying mechanisms are unclear. This is a retrospective post-hoc analysis of the YELLOW II trial, comparing patients with and without DM (non-DM) who received...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Surbhi Chamaria, Kipp W. Johnson, Yuliya Vengrenyuk, Usman Baber, Khader Shameer, Aparna A. Divaraniya, Benjamin S. Glicksberg, Li Li, Samit Bhatheja, Pedro Moreno, Akiko Maehara, Roxana Mehran, Joel T. Dudley, Jagat Narula, Samin K. Sharma, Annapoorna S. Kini
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/02e1b65f7bc7426a94ade020e84c3688
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:02e1b65f7bc7426a94ade020e84c3688
record_format dspace
spelling oai:doaj.org-article:02e1b65f7bc7426a94ade020e84c36882021-12-02T11:40:23ZIntracoronary Imaging, Cholesterol Efflux, and Transcriptomics after Intensive Statin Treatment in Diabetes10.1038/s41598-017-07029-72045-2322https://doaj.org/article/02e1b65f7bc7426a94ade020e84c36882017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-07029-7https://doaj.org/toc/2045-2322Abstract Residual atherothrombotic risk remains higher in patients with versus without diabetes mellitus (DM) despite statin therapy. The underlying mechanisms are unclear. This is a retrospective post-hoc analysis of the YELLOW II trial, comparing patients with and without DM (non-DM) who received rosuvastatin 40 mg for 8–12 weeks and underwent intracoronary multimodality imaging of an obstructive nonculprit lesion, before and after therapy. In addition, blood samples were drawn to assess cholesterol efflux capacity (CEC) and changes in gene expression in peripheral blood mononuclear cells (PBMC). There was a significant reduction in low density lipoprotein-cholesterol (LDL-C), an increase in CEC and beneficial changes in plaque morphology including increase in fibrous cap thickness and decrease in the prevalence of thin cap fibro-atheroma by optical coherence tomography in DM and non-DM patients. While differential gene expression analysis did not demonstrate differences in PBMC transcriptome between the two groups on the single-gene level, weighted gene coexpression network analysis revealed two modules of coexpressed genes associated with DM, Collagen Module and Platelet Module, related to collagen catabolism and platelet function respectively. Bayesian network analysis revealed key driver genes within these modules. These transcriptomic findings might provide potential mechanisms responsible for the higher cardiovascular risk in DM patients.Surbhi ChamariaKipp W. JohnsonYuliya VengrenyukUsman BaberKhader ShameerAparna A. DivaraniyaBenjamin S. GlicksbergLi LiSamit BhathejaPedro MorenoAkiko MaeharaRoxana MehranJoel T. DudleyJagat NarulaSamin K. SharmaAnnapoorna S. KiniNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Surbhi Chamaria
Kipp W. Johnson
Yuliya Vengrenyuk
Usman Baber
Khader Shameer
Aparna A. Divaraniya
Benjamin S. Glicksberg
Li Li
Samit Bhatheja
Pedro Moreno
Akiko Maehara
Roxana Mehran
Joel T. Dudley
Jagat Narula
Samin K. Sharma
Annapoorna S. Kini
Intracoronary Imaging, Cholesterol Efflux, and Transcriptomics after Intensive Statin Treatment in Diabetes
description Abstract Residual atherothrombotic risk remains higher in patients with versus without diabetes mellitus (DM) despite statin therapy. The underlying mechanisms are unclear. This is a retrospective post-hoc analysis of the YELLOW II trial, comparing patients with and without DM (non-DM) who received rosuvastatin 40 mg for 8–12 weeks and underwent intracoronary multimodality imaging of an obstructive nonculprit lesion, before and after therapy. In addition, blood samples were drawn to assess cholesterol efflux capacity (CEC) and changes in gene expression in peripheral blood mononuclear cells (PBMC). There was a significant reduction in low density lipoprotein-cholesterol (LDL-C), an increase in CEC and beneficial changes in plaque morphology including increase in fibrous cap thickness and decrease in the prevalence of thin cap fibro-atheroma by optical coherence tomography in DM and non-DM patients. While differential gene expression analysis did not demonstrate differences in PBMC transcriptome between the two groups on the single-gene level, weighted gene coexpression network analysis revealed two modules of coexpressed genes associated with DM, Collagen Module and Platelet Module, related to collagen catabolism and platelet function respectively. Bayesian network analysis revealed key driver genes within these modules. These transcriptomic findings might provide potential mechanisms responsible for the higher cardiovascular risk in DM patients.
format article
author Surbhi Chamaria
Kipp W. Johnson
Yuliya Vengrenyuk
Usman Baber
Khader Shameer
Aparna A. Divaraniya
Benjamin S. Glicksberg
Li Li
Samit Bhatheja
Pedro Moreno
Akiko Maehara
Roxana Mehran
Joel T. Dudley
Jagat Narula
Samin K. Sharma
Annapoorna S. Kini
author_facet Surbhi Chamaria
Kipp W. Johnson
Yuliya Vengrenyuk
Usman Baber
Khader Shameer
Aparna A. Divaraniya
Benjamin S. Glicksberg
Li Li
Samit Bhatheja
Pedro Moreno
Akiko Maehara
Roxana Mehran
Joel T. Dudley
Jagat Narula
Samin K. Sharma
Annapoorna S. Kini
author_sort Surbhi Chamaria
title Intracoronary Imaging, Cholesterol Efflux, and Transcriptomics after Intensive Statin Treatment in Diabetes
title_short Intracoronary Imaging, Cholesterol Efflux, and Transcriptomics after Intensive Statin Treatment in Diabetes
title_full Intracoronary Imaging, Cholesterol Efflux, and Transcriptomics after Intensive Statin Treatment in Diabetes
title_fullStr Intracoronary Imaging, Cholesterol Efflux, and Transcriptomics after Intensive Statin Treatment in Diabetes
title_full_unstemmed Intracoronary Imaging, Cholesterol Efflux, and Transcriptomics after Intensive Statin Treatment in Diabetes
title_sort intracoronary imaging, cholesterol efflux, and transcriptomics after intensive statin treatment in diabetes
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/02e1b65f7bc7426a94ade020e84c3688
work_keys_str_mv AT surbhichamaria intracoronaryimagingcholesteroleffluxandtranscriptomicsafterintensivestatintreatmentindiabetes
AT kippwjohnson intracoronaryimagingcholesteroleffluxandtranscriptomicsafterintensivestatintreatmentindiabetes
AT yuliyavengrenyuk intracoronaryimagingcholesteroleffluxandtranscriptomicsafterintensivestatintreatmentindiabetes
AT usmanbaber intracoronaryimagingcholesteroleffluxandtranscriptomicsafterintensivestatintreatmentindiabetes
AT khadershameer intracoronaryimagingcholesteroleffluxandtranscriptomicsafterintensivestatintreatmentindiabetes
AT aparnaadivaraniya intracoronaryimagingcholesteroleffluxandtranscriptomicsafterintensivestatintreatmentindiabetes
AT benjaminsglicksberg intracoronaryimagingcholesteroleffluxandtranscriptomicsafterintensivestatintreatmentindiabetes
AT lili intracoronaryimagingcholesteroleffluxandtranscriptomicsafterintensivestatintreatmentindiabetes
AT samitbhatheja intracoronaryimagingcholesteroleffluxandtranscriptomicsafterintensivestatintreatmentindiabetes
AT pedromoreno intracoronaryimagingcholesteroleffluxandtranscriptomicsafterintensivestatintreatmentindiabetes
AT akikomaehara intracoronaryimagingcholesteroleffluxandtranscriptomicsafterintensivestatintreatmentindiabetes
AT roxanamehran intracoronaryimagingcholesteroleffluxandtranscriptomicsafterintensivestatintreatmentindiabetes
AT joeltdudley intracoronaryimagingcholesteroleffluxandtranscriptomicsafterintensivestatintreatmentindiabetes
AT jagatnarula intracoronaryimagingcholesteroleffluxandtranscriptomicsafterintensivestatintreatmentindiabetes
AT saminksharma intracoronaryimagingcholesteroleffluxandtranscriptomicsafterintensivestatintreatmentindiabetes
AT annapoornaskini intracoronaryimagingcholesteroleffluxandtranscriptomicsafterintensivestatintreatmentindiabetes
_version_ 1718395621580210176